GeorgeSiberryMD

Pediatric Infectious Disease • New Haven, CT

Physician

Join to view full profile

Dr. Siberry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Siberry's full profile

Already have an account?

Office
789 Howard Ave
New Haven, CT 06519
Phone+1 203-688-5555

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Infectious Diseases, 2000 - 2003
Johns Hopkins UniversityChief Residency, Pediatrics, 1998 - 1999
Johns Hopkins UniversityResidency, Pediatrics, 1994 - 1997
Johns Hopkins University School of Hygiene & Public HealthMPH, International Health, 1992 - 1994
Johns Hopkins University School of MedicineClass of 1994

Certifications & Licensure

CT State Medical License 2018 - 2025
MD State Medical License 2001 - 2025
NY State Medical License 2021 - 2025
PA State Medical License 1997 - 2000
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries Start of enrollment: 2002 Jul 25
Completed
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth Start of enrollment: 2007 Jun 01
Completed
Phase 1, Phase 2
Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents Start of enrollment: 2009 Nov 01
Completed
Phase 2
Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding Start of enrollment: 2011 Mar 22
Completed
Join now to see all

Publications & Presentations

PubMed

158 citations
Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States
Sybil G. Hosek, Raphael J. Landovitz, Bill G. Kapogiannis, George K. Siberry, Bret J. Rudy
JAMA Pediatrics. 2017-11-01
2 citations
Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected in...
Lynda Stranix-Chibanda, Camlin Tierney, Mauricio Pinilla, Kathleen George, Jim Aizire
Plos One. 2021-08-20
6 citations
Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial
Lynda Stranix-Chibanda, Camlin Tierney, Dorothy Sebikari, Jim Aizire, Sufia Dadabhai
Plos One. 2021-02-05

Press Mentions

FDA Advisers Vote to Recommend Authorization of a Pill to Treat Covid-19November 30th, 2021
Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and Without HIV Infection in Latin AmericaNovember 14th, 2017
Maternal Tenofovir Use May Not Adversely Affect Bone Mineral Content in InfantsFebruary 25th, 2016
Join now to see all

Professional Memberships

American Academy of Pediatrics - AAP
Fellow
Infectious Disease Society of America - IDSA
Fellow
Pediatric Infectious Disease Society (PIDS)
Fellow